University of Leicester
Browse

Illustration of different modelling assumptions for estimation of loss in expectation of life due to cancer.

Download (827.13 kB)
journal contribution
posted on 2019-07-30, 08:22 authored by Therese M.-L. Andersson, Mark J. Rutherford, Paul C. Lambert
BACKGROUND: The life expectancy of cancer patients, and the loss in expectation of life as compared to the life expectancy without cancer, is a useful measure of cancer patient survival and complement the more commonly reported 5-year survival. The estimation of life expectancy and loss in expectation of life generally requires extrapolation of the survival function, since the follow-up is not long enough for the survival function to reach 0. We have previously shown that the survival of the cancer patients can be extrapolated by breaking down the all-cause survival into two component parts, the expected survival and the relative survival, and make assumptions for extrapolation of these functions independently. When extrapolating survival from a model including covariates such as calendar year, age at diagnosis and deprivation status, care has to be taken regarding the assumptions underlying the extrapolation. There are often different alternative ways for modelling covariate effects or for assumptions regarding the extrapolation. METHODS: In this paper we describe and discuss different alternative approaches for extrapolation of survival when estimating life expectancy and loss in expectation of life for cancer patients. Flexible parametric models within a relative survival setting are used, and examples are presented using data on colon cancer in England. RESULTS: Generally, the different modelling assumptions and approaches give small differences in the estimates of loss in expectation of life, however, the results can differ for younger ages and for conditional estimates. CONCLUSION: Sensitivity analyses should be performed to evaluate the effect of the assumptions made when modelling and extrapolating survival to estimate the loss in expectation of life.

Funding

This work was supported by Cancer Research UK [Grant number C1483/A18262], Cancerfonden and Vetenskapsrådet.

History

Citation

BMC Medical Research Methodology, 2019, 19, 145

Author affiliation

/Organisation/COLLEGE OF LIFE SCIENCES/School of Medicine/Department of Health Sciences

Version

  • VoR (Version of Record)

Published in

BMC Medical Research Methodology

Publisher

BMC (part of Springer Nature)

eissn

1471-2288

Acceptance date

2019-06-25

Copyright date

2019

Available date

2019-07-30

Publisher version

https://bmcmedresmethodol.biomedcentral.com/articles/10.1186/s12874-019-0785-x

Notes

The data that support the findings of this study are available from Public Health England (https://www.gov.uk/government/publications/accessing-public-health-england-data/about-the-phe-odr-and-accessing-data), but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available.

Language

en

Usage metrics

    University of Leicester Publications

    Categories

    No categories selected

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC